Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. А. Sorokina"'
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 291-302 (2023)
Today, it is difficult to overestimate the new directions in the pharmacotherapy of peripheral T-cell lymphomas (PTCL): immunotherapy, including adoptive, targeted therapy and chemotherapy. However, there are few biomarkers that predict response to t
Externí odkaz:
https://doaj.org/article/5a0887d944a34f6ea4c3e01ab3e566a0
Autor:
M. А. Sorokina, T. R. Grishina
Publikováno v:
Фармакоэкономика, Vol 16, Iss 1 (2023)
High-throughput next-generation sequencing (NGS) technologies such as whole exome sequencing (WES) and bulk RNA sequencing (RNA-seq) allow identification of the new biomarkers of response and resistance to antitumor therapy. Retrospective studies hav
Externí odkaz:
https://doaj.org/article/cc2e0d2494f247219a137afb0502515c